BioScreening News

  • Seegene Receives US Patent for TOCE Technology
    Gaithersburg, Maryland and SEOUL, Korea, November 19, 2014 - Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that it has been issued a United States Patent, No. 8,809,239, for its tagging oligonucleotide capture and extension (TOCE™) technology, which enables highly multiplexed target amplification and detection in...
  • The Market for Therapeutic Biologicals is Evolving as Pipeline Candidates Reach Commercialization
    The Convergence of New Biologicals and the Growth of Biosimilars Will Require Changes at FDA according to Greystone Research Associates (Amherst, NH) – Activity in the biological drug sector is set to escalate, as a growing number of drug candidates reach the market and the number of applications requesting marketing...
  • Stem cells from human body fat used to deliver treatment for deadly glioblastoma in mice
    Johns Hopkins researchers say they have successfully used stem cells derived from human body fat to deliver biological treatments directly to the brains of mice with the most common and aggressive form of brain tumor, significantly extending their lives. In the mouse experiments, the Johns Hopkins investigators used mesenchymal stem...
  • NIH lays out plan to work exome data into clinical research
    Having seen the cost of exome sequencing tumble in recent years, the National Institutes of Health (NIH) has decided now is the time to jump-start its genomic medicine program. The upshot is more clinical research programs will soon have access to exome sequencing capabilities and NIH support with management of...
  • Positing Parkinson’s as an autoimmune disease
    Parkinson’s disease, like Alzheimer’s disease, is one of the leading neurodegenerative issues being targeted by the biopharmaceutical and life sciences industries today. It is the result of the death of neurons responsible for producing dopamine, which the Parkinson’s Disease Foundation describes as “A chemical messenger that regulates movement by assisting...
  • UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development
    At a time when Big Pharma is increasingly tapping academic institutions for expertise in informatics and data-driven computer models for drug discovery, the FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco (UCSF) for a new initiative aimed at streamlining the drug development and...
  • Novavax, U. of Maryland report positive preclinical results for MERS vaccine
    With the arrival of Middle East respiratory syndrome coronavirus in the U.S. and a rising death toll in Saudi Arabia, a vaccine designed by Novavax ($NVAX) and the University of Maryland has shown promise in blocking the infection in animals. In a study published in Vaccine, researchers describe a novel...
  • Harvard’s bone marrow-on-a-chip could replace animal drug testing
    Scientists at Harvard’s Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed “bone marrow-on-a-chip,” the first device of its kind that mimics the structure, functions and cellular make-up of bone marrow. Bone marrow is made up of complex tissue and has, up until now,...

eChemShop - Chemical Reagents and Equipment

TimTec Compound Libraries

Upcoming Events

View full calendar

Life Science Events

October 2014 November 2014 December 2014
Su Mo Tu We Th Fr Sa
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinMixxRSS Feed